New hope to stop colon cancer from coming back
NCT ID NCT07140679
Summary
This study tests whether an immunotherapy drug called toripalimab can help prevent cancer from returning after surgery in people with high-risk colon cancer that has a specific genetic feature. About 40 patients who have had their colon cancer surgically removed will receive the drug through an IV every 3 weeks for 6 months. Researchers will track patients for up to 5 years to see if the treatment improves survival and reduces the chance of the cancer coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED COLON CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory Decatur Hospital
RECRUITINGAtlanta, Georgia, 30033, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Emory Johns Creek Hospital
RECRUITINGJohns Creek, Georgia, 30097, United States
Contact Email: •••••@•••••
Contact
-
Emory Saint Joseph's Hospital
RECRUITINGAtlanta, Georgia, 30342, United States
Contact Email: •••••@•••••
Contact
-
Emory University Hospital Midtown
RECRUITINGAtlanta, Georgia, 30308, United States
Contact Email: •••••@•••••
Contact
-
Emory University Hospital/Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.